Mind glue: Implications of glial cell biology for psychiatry

Archives of General Psychiatry

Volumn 57, Issue 1, 2000, Pages 90-93

  Coyle, Joseph T ^a   Schwarcz, Robert ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTROPHIC FACTOR;

BRAIN FUNCTION; GLIA; GLIA CELL; HUMAN; MACROGLIA; MENTAL DISEASE; MICROGLIA; NEUROBIOLOGY; NEUROTRANSMISSION; NEUROTROPISM; SHORT SURVEY; STEM CELL;

EID: 0033976985     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.57.1.90     Document Type: Short Survey

References (58)

1. Bignami A. Glial cells in the central nervous system. In: Discussions in Neuroscience. Vol 8. Amsterdam, the Netherlands: Elsevier Science Publishers; 1991:1-45.
2. Virchow R. Über das granulierte Ansehen der Wandungen der Gerhirnventrikel. Allg Z Psychiatr. 1846;3:242.
3. Harris KM, Rosenberg PA. Localization of synapses in rat cortical cultures. Neuroscience. 1993; 53:495-508.
4. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science. 1999;283:496-497.
5. Magistretti PI, Pellerin L. The cellular bases of functional brain imaging: evidence for astrocyticneuron metabolic coupling. Neuroscientist. 1997; 3:361-365.
6. Magistretti PJ, Pellerin L. Cellular bases of energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. Cereb Cortex. 1996;6:50-61.
7. Swanson RA, Morton MM, Sagar SM, Sharp FR. Sensory stimulation induces local cerebral glycogenoiysls: demonstration by autoradiography. Neuroscience. 1992;52:1359-1365.
8. Michaelis EK. Two different families of NMDA receptors: physiologic function and role in neuronal development and degeneration. In: Grisola S, Felips V, eds. Advances in Experimental Medicine and Biology. Vol 341. New York, NY: Plenum Press; 1994:119-138.
9. Olney JW. Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicoil. 1990;30:47-71.
10. Krystal JH, Karper LP. Seibyl JP, Freeman GK, Delaney R, Brenner JP, Heninger GR, Bowers MB, Charney DS. Subanesthetic effects of the non-competitive NMDA receptor antagonist, ketamine, in humans: psychotomímetìc, perceptual, cognitive, and neuroendocrine responses. Arsh Gen Psychiatry. 1994;51:199-214.
11. + dependent glutamate/aspartate transporters from rat brain. Proc Natl Acad Sci U S A. 1992;89:10955-10959.
12. Berger UV, Hedlger MA. Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization. Anat Embryol (Berl). 1998;198:13-30,
13. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takanashi K, Iwama H, Nishikawa T, Ichihava N, Hovi S. Epilepsy and exacerbation of brain injury In mice lacking the glutamate transporter GLT-1. Science. 1997;276:1699-1702.
14. Dingiedine R, Kleckner NW, McBain CJ. The glycine co-agonist site of the NMDA receptor. In: Ben-Ari Y, ed. Excitatory Amino Acids and Neuronal Plasticity. New York, NY: Plenum Press; 1990; 17-26.
15. Adams RH, Sato K, Shimada S, Tohyama M, Puschel AW, Betz H. Gene structure and glial expression of the glycine transporter GlyT1 in embryonic and adult rodents. J Neurosci. 1995;15:2524-2532.
16. Bergeron R, Meyer TM, Coyle JT, Greene RW. Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc Natl Acad Sci U S A. 1998;95:15730-15734.
17. Wolosker H, Sheth KN, Takahashi M, Mothet JP, Brady RO, Ferres CD, Snyder SH. Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc Natl Acad Sci U S A. 1999; 86:721-725.
18. Tsai G, Yang P, Chung L-C, Lange N, Coyle JT. D-Serine added to antipsychotics for treatment of schizophrenia. Biol Psychiatry. 1998;44:1081-1089.
19. Tsai G, Falk W, Gunther J, Coyle JT. Improved cognition in Alzheimer's disease with short term D-cycloserine treatment. Am J Psychiatry. 1999; 156:467-469.
20. Stone TW. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev. 1993;45:309-379.
21. Schwarcz R, Guidetti P, Roberts RC. Quinolinic acid and kynurenic acid: glia-derived modulators of excitotoxic brain injury. In: Aschner M, Kimelberg H, eds. The Role of Glia in Neurotoxicity. Boca Raton, Fla: CRC Press LLC; 1996:245-262.
22. Speciale C, Schwarcz R. On the production and disposition of quinolinic acid in rat brain and liver slices. J Neurochem. 1993;60:212-218.
23. Gramsbergen JBP, Hodgkins PS, Rassoulpour A, Turski WA, Guidetti P, Schwarcz R. Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem. 1997;69:290-298.
24. Foster AC, Miller LP, Oldendorf WH, Schwarcz R. Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat. Exp Neurol. 1984;84:428-440.
25. Heyes MP, Saito K, Lackner A, Wiley A, Achim CL, Markey SP. Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J. 1998;12:881-896.
26. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der Mand Markey SP. Interrelationships between quinolinic acid, neuroactive kynurenines, neopterin and 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol. 1992;40:71-80.
27. Heyes MP, Saito H, Crowley JS, Davies LE, Demitrak MA, Der M, Dilling L, Kruesi MJP, Lackner A, Larson SA, Lee K, Leonard H, Markey SP, Martin A, Milstien S, Mouradian MM, Pranzatelli MR, Quearry BJ, Salazar AM, Smith ML, Straus SE, Sunderland T, Swedo S, Tourtelotte WW. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurologic disease. Brain. 1992;115:1249-1273.
28. Coyle JT. The nagging question of the function of N-acetylaspartylglutamate. Neurobiol Dis. 1997; 4:231-238.
29. Hökfelt T, Johansson O, Ljungdahl A, Lundberg JM, Schulzberg M. Peptidergic neurons. Nature. 1980;284:515-521.
30. Blakely RD, Robinson MB, Thompson RC, Coyle JT. Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate (NAAG): subcellular and regional distribution, ontogeny and effects of lesions on NAALADase. J Neurochem. 1988;50: 1200-1209.
31. Carter RL, Berger UV, Barczak AK, Enna M, Coyle JT. Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc Natl Acad Sci U S A. 1998;95:3215-3220.
32. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman J, Coyle JT. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry. 1995;52:829-836.
33. Rothstein JD, Tsai G, Kunel RW, Clawson L, Cornblath DR, Drachman DB, Pestronk A, Stauch BL, Coyle JT. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol. 1990;28:18-25.
34. Passani LA, Vonsattel JPG, Carter RE, Coyle JT. N-acetylaspartylglutamate, N-acetylaspartate and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington's and Alzheimer's disease. Mol Chem Neuropathol. 1997; 31:97-118,
35. Fletcher EJ, Millar JD, Zeman S, Lodge D. Non-competitive antagonism of N-methyl-D-aspartate by displacement of an endogenous glycine-like substance. Eur J Neurosci. 1989;1:196-203.
36. Ceresoli-Borroni G, Guidetti P, Schwarcz R. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats. J Neural Transm. 1999;106:229-242.
37. Wu HQ, Schwarcz R. Seizure activity causes elevation of endogenous extracellular kynurenic acid in the rat brain. Brain Res Bull 1996;39:155-162.
38. Rassoulpour A, Ceresoli-Borroni G, Wu H-Q, Tamminga CA, Roberts RC, Medoff DR, Schwarcz R. Cerebral kynurenines in schizophrenia: a post-mortem study. Soc Neurosci Abstracts. 1998; 24. Abstract 194.9.
39. Beal MF, Matson WR, Storey E, Milbury P, Ryan EA, Ogawa T, Bird ED. Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J Neurol Sci. 1992;108:80-87.
40. Jauch D, Urbánska E, Guidetti P, Bird ED, Vonsattel J-PG, Whetsell WO, Schwarcz R. Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases. J Neurol Sci. 1995;130:39-47.
41. David JC, Yamada KA, Bagwe MR, Goldberg MP. AMPA receptor activation is rapidly toxic to cortical astrocytes when desensitization is blocked. J Neurosci. 1996;16:200-209.
42. Gallo V, Russell JT. Excitatory amino acid receptors in glia: different subtypes for distinct functions. J Neurosci Res. 1995;42:1-8.
43. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science. 1994;263:1768-1771.
44. Lindsay RM, Wiegand SJ, Altar CA, DiStefano PS. Neurotrophic factors: from molecule to man. Trends Neurosci. 1994;17:182-189.
45. Kotzbauer PT, Lampe PA, Heuckeroth RO, Golden JP, Creedon DJ, Johnson EM, Milbrandt J. Neuturin, a relative of glial-cell-line derived neurotrophic factor. Nature. 1996;384:467-470.
46. Choi-Lundberg DL, Lin Q, Chang Y-N, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 1997;275: 838-841.
47. Duman RS, Vaidya VA, Nibuyer M, Morimbu S, Fitzgerald LR. Stress, antidepressant treatments and neurotrophic factors: molecular and cellular mechanisms. Neuroscientist. 1995;1:351-360.
48. Carson MJ, Sutcliffe JG. Balancing function vs self defense: the CNS as an active regulator of immune responses. J Neurosci Res. 1999;55:1-8.
49. Spranger M, Fontana A. Activation of microglia: a dangerous interlude in immune function in the brain. Neuroscientist. 1996;2:293-299.
50. Chao CC, Hu S, Peterson PK. Glia, cytokines and neurotoxicity. Crit Rev Neurobiol. 1995;9:189-205.
51. Mattson MP, Rydel RE. Amyloid ox-tox transducers. Nature. 1996;382:674-675.
52. Wyss-Coray T, Masliah E, Mallory M, McConologue L, Johnson-Wood K, Lin C, Mucke L. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature. 1997; 389:603-607.
53. Rogers JT, Leiter LM, McPhee J, Cahill C, Zhan S-S, Potter H, Nilsson LNG. Translation of the Alzheimer amyloid precursor protein mRNA is upregulated by interleukin-1 through 5′-untranslated region sequences. J Biol Chem. 1999; 274:6421-6431.
54. Björklund A, Svendsen C. Stem cells: breaking the brain-blood barrier. Nature. 1999;397:569-570.
55. Parent J, Wu TW, Leibowitz RT, Geschwind DH, Sloviter RS, Lowenstein DH. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization. J Neurosci. 1997;17:3727-3738.
56. Lin J, Solway K, Messing RO, Sharp FR. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J Neurosci. 1998;18:7768-7778.
57. Ongur D, Drevets WC, Price JL. Glial reduction in the subgeneral prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95:13290-13295.
58. Selemon LD, Lidow MS, Goldman-Rakic P. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol Psychiatry. 1999;46: 161-172.